![Magnus Persson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Magnus Persson
Presidente presso Trailhead Biosystems, Inc.
Posizioni attive di Magnus Persson
Società | Posizione | Inizio | Fine |
---|---|---|---|
Trailhead Biosystems, Inc.
![]() Trailhead Biosystems, Inc. Medical SpecialtiesHealth Technology Trailhead Biosystems, Inc. develops cell therapies. Its program includes cancer immunotherapy, bone induction, neural fate space project, kidney and blood program. The company was founded by Jan Jensen in 2013 and is headquartered in Cleveland, OH. | Presidente | - | - |
Strike Pharma AB
![]() Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Magnus Persson
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Svezia | 2 |
Posizioni
Chairman | 1 |
Director/Board Member | 1 |
Settori
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Trailhead Biosystems, Inc.
![]() Trailhead Biosystems, Inc. Medical SpecialtiesHealth Technology Trailhead Biosystems, Inc. develops cell therapies. Its program includes cancer immunotherapy, bone induction, neural fate space project, kidney and blood program. The company was founded by Jan Jensen in 2013 and is headquartered in Cleveland, OH. | Health Technology |
Strike Pharma AB
![]() Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Commercial Services |
- Borsa valori
- Insiders
- Magnus Persson
- Esperienza